Finally, the immune-evasion potential of CHSY3 in STAD was assessed on the Tumor Immune Dysfunction and Exclusion (TIDE) website and immunohistochemical staining experiment. This evidence concerns the gene CHSY3 and gastric adenocarcinoma.